Paul Sagan $MRNA SEC Form 4 Insider Trading

Paul Sagan has filed a total of 2 insider trades in $MRNA since 2021. Their most recent trade was a purchase of 31,620 shares, made on Mar 03, 2025. Their largest trade was a purchase of 31,620 shares, made on Mar 03, 2025. We estimate that they now own shares of $MRNA, worth an estimated $10.4 million.

Insider Trading at $MRNA

There have been a total of 1436 insider trades reported at $MRNA since 2021, with 191,934 shares purchased and 8.7 million shares sold. The most active insider traders in $MRNA stock have been Stephane Bancel, Stephen Hoge, and Juan Andres. The most recent trade was a purchase of 57,493 shares reported by Stephane Bancel (Chief Executive Officer), made on Mar 03, 2025.

$MRNA Executives and Stock Owners with Insider Trades

• Stephane Bancel, Chief Executive Officer

• Stephen Hoge, President

• Juan Andres, See remarks

• Shannon Thyme Klinger, Chief Legal Officer

• James M Mock, Chief Financial Officer

• Tal Zvi Zaks, Chief Medical Officer

• Arpa Garay, Chief Commercial Officer

• David W Meline, Chief Financial Officer

• Paul Burton, Chief Medical Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.